Vertex Pharmaceuticals Inc / Ma

Qube Research & Technologies Ltd VRTX

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

51,382

Value ($000)

20,123

Weight

0.0%

2019 Q4 - 2025 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	20,123	0.0%	51,382	9/30/2025
2025 Q2	8/14/2025	2,529	0.0%	5,681	6/30/2025
2025 Q1	5/15/2025	16,749	0.0%	34,546	3/31/2025
2024 Q3	11/14/2024	60,998	0.1%	131,156	9/30/2024
2024 Q2	8/14/2024	212,505	0.4%	453,373	6/30/2024
2024 Q1	5/14/2024	233,474	0.4%	558,536	3/31/2024
2023 Q4	2/13/2024	189,214	0.4%	465,025	12/31/2023
2023 Q3	11/13/2023	145,741	0.4%	419,109	9/30/2023
2023 Q2	8/14/2023	28,029	0.1%	79,647	6/30/2023
2022 Q4	2/14/2023	123,462	0.7%	427,529	12/31/2022
2022 Q3	11/14/2022	28,059	0.2%	96,910	9/30/2022
2021 Q3	11/12/2021	7,906	0.1%	43,583	9/30/2021
2021 Q1	5/14/2021	6,199	0.1%	28,845	3/31/2021
2020 Q3	11/12/2020	5,522	0.1%	20,293	9/30/2020
2020 Q2	8/14/2020	4,231	0.1%	14,573	6/30/2020
2020 Q1	5/15/2020	930	0.0%	3,908	3/31/2020
2019 Q4	2/13/2020	3,023	0.1%	13,809	12/31/2019